DEI Special Edition Spring / Summer 2024
That does not mean, however, that its not something worth developing to en- hance our community service.
As CRAs, you have a unique opportunity not to discourage innovation to enhance Autism DEI, but rather to unite our research community under a standard of ac- ceptance. You have eyes and ears in so many different site environments, and therefore the power to help sites struggle through creating their new systems DCT and DEI logistics. Know the regulations, be the guides your sites need, and the advocates for our community patients. And so – as you complete your monitoring visit and review your standard source at your standard site – please know there are thousands of patients out there you are not seeing. They are willing to follow the study protocol to the “ t ”, literally, they suffer from indications that our trials could help with, they will likely be one of the end - patients who rely on these new therapies are approved, and they are denied the opportunity to participate in your clinical trial not because of choice or protocol exclusion, but because we as clinical research professionals are unwilling to adapt our processes, even with the defensible regulatory guidance right in front of our eyes, to accommodate their needs. Please – do not deny willing and qualified autistic patients the ability to be autistic participants. Imagine what this population ’ s enrollments could do for our entire industry – if we only worked together to create an industry structure that wel- comes them into our trials.
Daniel Fox, MPH, PhD
Daniel Fox, MPH, PhD is the Founder of Clinical Research Payment Network and Land of Lincoln Clinical Research. He has also co - founded and led as an executive the Save Our Sites alliance and two non - profits dedicated to supporting our autistic communities. As if that were not enough Dr. Fox is Co - Founder of DiversiTrials" and he is an official di- versity Reviewer for the Global Public Health Credentialing Board. After losing his child to a rare disease, Dr. Fox dedicates his life to ensuring everyone, EVERYONE, can access clinical trials regardless of their age, race, disability, gender, gender identity, socioeco- nomic status, or geographic location. If you feel as strongly as he does about clinical research rights in across our communities, please reach out and join his mission.
27
Made with FlippingBook - professional solution for displaying marketing and sales documents online